Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 324 A D V A M E D 2 0 1 5 A N N U A L R E P O R T AMPLIFYINGYOUR VOICE AdvaMed is the world’s leading medical technology trade association, with member companies that develop, manufacture and sell innovative medical devices and diagnostic products. AdvaMed supports the needs of members of all sizes – from cutting edge, entrepreneurial start-ups to emerging growth and mid-size companies to the largest innovators and manufacturers. As the voice for a unified industry, AdvaMed is uniquely positioned to advocate for policies that support value creation and patient access to innovation, to proactively address and shape laws and regulations, and to ensure the highest ethical standards for industry interactions with health care providers. From winning a two-year suspension of the medical device tax, to advancing legislation in support of 21st century cures, to increasing harmonization of global ethical standards, AdvaMed’s progress in 2015 reflects the Association’s ability to harness the collective view of its 300 members to achieve positive results for the industry and the economy, and for patient care. Through its staff of more than 70 experts, AdvaMed offers members knowledgeable guidance in areas critical to industry’s success: technology and regulatory affairs, payment and health care delivery policy, legal and compliance, global strategy and analysis, and government and public affairs. AdvaMed also offers a range of opportunities for member interaction and cooperation, including the Women’s Executive Network, educational workshops and webinars, and industry- driven working groups and committees that help develop feedback and positions on policies that affect every sector of the medtech industry. M E M B E R S H I P P R O F I L E I N I N N O VAT I O N At the age of 14, Joe Abdo began having seizures and was diagnosed with epilepsy. When medication proved ineffective, an MRI was ordered, revealing that Joe had a brain tumor. Doctors used intraop- erative MRI technology to fully remove his tumor. Today, Joe is cancer-free and a proud husband and father, working at a molecular diagnostics company as a way to give back to a field that saved his life. MEMBERSHIP BREAKDOWN BY U.S. SALES: n Associate Members = 10% n Emerging Growth Members (< $100 mil.) = 66% n Mid-size Members ($100 mil.-$500 mil.) = 12% n Large Members (> $500 mil.) = 12% 10% 12% 12% 66% A D V A M E D 2 0 1 5 A N N U A L R E P O R T